- Inclusion Criteria
- Exclusion Criteria
- Enrolled in this study
- Basic patient information
- Hospital inspection
- Randomized result
|
Inclusion criteria |
|
Exclusion Criteria |
|
Is this patient enrolled in this study | |
|
Reason for recruitment failure |
|
|
Sex |
|
Age | 岁 |
|
Hypertension | |
|
valvular hear disease or infective endocarditis | |
|
Diabetes | |
|
Hyperlipidemia | |
|
Coronary heart disease | |
|
Atrial fibrillation | |
|
TIA | |
|
Cerebral infarction | |
|
Smoking | |
|
Stenosis or stenting |
|
|
Bradycardia, hypercoagulability, tumor, and other medical history |
|
|
Modified Rankin scale score | |
|
Pre-stroke disability mRS score |
|
|
Addmission systolic blood pressure | mmHg |
|
Addmission diastolic blood pressure | mmHg |
|
Platelet | *10^9/L |
|
Blood glucose，Glu | mmol/L |
|
Hemoglobin A1c，HbA1C | % |
|
Triglyceride，TG | mmol/L |
|
Total cholesterol，TC | mmol/L |
|
Low density lipoprotein cholesterin，LDLC | mmol/L |
|
International normalized ratio，INR |
|
|
Baseline NHISS |
|
|
Baseline ASPECTS |
|
|
Randomized result |
- Date frame
- Intravenous thrombolysis
- Postoperative NIHSS score at 24h
- Anesthesia method
- Operation method
- Intraoperative drug therapy
- occlusion site(CTA/MRA)
- occlusion site(DSA)
- Tandem lesion
- Site of extracranial lesions
- Recanalization of blood flow
- Cause of stroke
- Collateral circulation
|
Onset time | yyyy/yy/yy yy:yy |
|
Visiting time | yyyy/yy/yy yy:yy |
|
CT/MR image time | yyyy/yy/yy yy:yy |
|
Randomization time | yyyy/yy/yy yy:yy |
|
Intravenous thrombolysis time | yyyy/yy/yy yy:yy |
|
Groin puncture time | yyyy/yy/yy yy:yy |
|
Recanalization end time | yyyy/yy/yy yy:yy |
|
Intravenous thrombolysis |
|
Postoperative NIHSS at 24h |
|
|
Anesthesia method |
|
Name of operation method |
|
|
Type of endovascular treatment intracranial | |
|
Type of endovascular treatment extracranial | |
|
First pass effect | |
|
Rescue therapy | |
|
Number of stent retriever passes | |
|
Number of aspiration passes | |
|
First choice of endovascular treatment | |
|
Thrombectomy device |
|
|
Balloon Name and Type |
|
|
Intra-arterial thrombolytic medication | |
|
Dosage of intra-arteria thrombolytic | mg/万U |
|
Intra-arterial tirofiban | |
|
Dosage of intra-arterial tirofiban | ml |
|
Occlusion sites（CTA/MRA） |
|
Occlusion sites(DSA) |
|
Tandem lesion |
|
Site of extracranial lesions |
|
Extended thrombolysis in cerebral infarction score（eTICI） |
|
TOAST classification by EVT |
|
ASITN/SIR grade |
- Discharge NHISS
- Postoperation reocclusion
- Confirmation method of postoperative reocclusion
- Technical complications
- Cerebral hemorrhage
- hemorrhage type
- Postoperative complications
|
NHISS at 5-7days or discharge |
|
|
Postoperation reocclusion |
|
Postoperative reocclusion examination method |
|
Arterial perforation | |
|
Arterial dissection | |
|
Embolization into a new territory | |
|
Cerebral vasospasm requiring treatment | |
|
Perforating artery rupture | |
|
Other | |
|
Venous thrombosis |
|
Intracerebral hemorrhage |
|
Intracerebral hemorrhage type |
|
Cerebral hernia | |
|
Decompressive craniectomy | |
|
Pulmonary infection | |
|
Respiratory failure | |
|
Circulatory failure | |
|
Venous thrombosis | |
|
Death in hospital | |
|
Systemic hemorrhage | |
|
Other |
|
|
mRS at 90 days | |
|
Date of death | yyyy/yy/yy yy:yy |
|
EQ-5D-5L score |
|
|
Date of signature | yyyy-mm-dd |
|
Signature of the monitor |
|